Link to All Articles

Jan 17 2008, 11:54 AM EST
Invitrogen Set to Provide Comprehensive Noncoding RNA Portfolio
With the license from IMBcom, Invitrogen will be able to expand its NCode™ miRNA microarray product line. Full Story

Jan 17 2008, 11:55 AM EST
LabCorp to Commercialize Lung Cancer Detection Device with Right's from Duke University
Collaborators will carry out additional clinical research with the intent of using the technology along with traditional methods. Full Story

Jan 16 2008, 12:01 PM EST
Scil Could Receive Up To $250M from Pfizer for Access to Cartilage Growth Factor
CD-RAP is viewed as a promising candidate for cartilage regeneration in indications such as chondral defects and osteoarthritis. Full Story

Jan 16 2008, 11:54 AM EST
FAB Awarded SBIR Grant to Advance Cell-Free Protein Synthesis Platform
NSF $500,000 phase IIb funding follows success from STTR phase I and II projects. Full Story

Jan 15 2008, 11:54 AM EST
Alfacell Signs Over U.S. Rights for Oncology Drug to Strativa in Deal Worth $225M
Agreement related to late-stage candidate, Onconase, calls for $5 million upfront and $30 million upon FDA approval. Full Story

Jan 15 2008, 11:52 AM EST
Genzyme to Pursue Prognostic Test for NSCLC with License from Moffitt
Device will measure expression levels of two proteins that researchers found to correlate with response to platinum therapeutics and gemcitabine. Full Story

Jan 14 2008, 12:18 PM EST
SAFC Moves to Increase Biologics Production Capacity
Company plans $12 million, 8,000 sq. ft. expansion for Carlsbad, CA, site. Full Story

Jan 11 2008, 11:29 AM EST
Researchers Identify Mechanism for Vaccines to Target HIV Protein
Paper in Immunity showed that the MPER region of gp41 is hidden in viral membranes but certain antibodies can expose it. Full Story

Jan 11 2008, 11:32 AM EST
Scientists Develop Water-Soluble Nanoarray for RNA
This array, which lacks a solid surface chip and acts as a reagent, is single-molecule specific, according to study published in Science. Full Story

Jan 11 2008, 11:31 AM EST
Ipsen Life Sciences Program to Be Created at the Salk Institute
Ipsen will fund research in proliferative and degenerative diseases. Full Story

GenEngNews.com